Thousand Oaks Strengthens Its Growing Biotechnology and Life Sciences Industry
Kite Pharma is bringing its home office closer to the heart of Ventura County's growing biotechnology industry, announcing plans to relocate its headquarters operations from Santa Monica to two locations in Thousand Oaks and El Segundo by the end of 2026.
The move represents another significant development for the Conejo Valley, which has become an increasingly important center for biotechnology, pharmaceutical research and life sciences companies in Southern California.
For Thousand Oaks and the surrounding communities, Kite Pharma's relocation adds another major name to a local industry anchored by biotechnology giant Amgen and supported by a growing collection of life sciences companies.
Kite Pharma Moving to Thousand Oaks and El Segundo
Kite Pharma, a biotechnology company specializing in engineered cell therapies for cancer, announced on LinkedIn that it plans to move its home office operations at the end of 2026.
The company currently has its headquarters in Santa Monica. Under the planned relocation, Kite will establish its home office presence in two Southern California locations: Thousand Oaks in Ventura County and El Segundo in Los Angeles County.
For residents and businesses in the Conejo Valley, the Thousand Oaks location is particularly noteworthy.
The relocation further establishes Thousand Oaks as an important destination for biotechnology companies, pharmaceutical businesses and life sciences professionals looking for a presence in Southern California.
What Is Kite Pharma?
Kite Pharma is a biotechnology company focused on developing engineered cell therapies designed to help treat cancer.
The company is particularly known for its work in cell therapy, an area of medicine that uses modified cells as part of an approach to treating serious diseases. Kite's work has helped make it a recognized name in the rapidly evolving field of cancer treatment and biotechnology.
Kite was founded in 2009 and was acquired by Gilead Sciences in 2017 in a deal valued at approximately $11.9 billion.
Despite the acquisition, Kite operates as an independent subsidiary of Gilead Sciences.
The company has expanded its operations beyond Southern California, with another facility in Oceanside as well as operations in Maryland and Europe.
Thousand Oaks Continues to Build Its Biotech Industry
Kite Pharma's relocation comes as the Conejo Valley continues to develop its reputation as a biotechnology and life sciences hub.
Thousand Oaks is home to Amgen, one of the world's largest biotechnology companies and one of the most prominent employers in the region. The presence of Amgen has helped establish a foundation for a broader life sciences ecosystem in the Conejo Valley.
The local cluster includes approximately 20 other life sciences companies, many of them located in Thousand Oaks.
Among the companies connected to the region's growing biotechnology sector are Atara Biotherapeutics, Capsida Biotherapeutics, Latigo Biotherapeutics and Tokyo-based Takeda Pharmaceuticals.
The concentration of biotechnology and pharmaceutical companies creates opportunities for professionals in research, laboratory science, engineering, technology, manufacturing, administration and other specialized fields.
Why Kite Pharma's Move Matters to the Conejo Valley
The arrival of Kite Pharma's home office operations is significant beyond the company itself.
A larger biotechnology presence can contribute to the region's economy by bringing highly skilled jobs, attracting additional businesses and strengthening the network of companies that support the life sciences industry.
Biotechnology companies often require a wide range of professional services, including legal, financial, technology, commercial real estate, construction, consulting, marketing and other business services.
That means growth in the local biotech sector can have an impact well beyond the companies conducting research and developing treatments.
For Thousand Oaks, Kite Pharma's planned relocation is another indication that the city is becoming an increasingly attractive location for life sciences companies.
Conejo Valley's Strategic Location for Life Sciences
The Conejo Valley offers biotechnology companies access to the broader Southern California economy while providing a business environment outside the region's largest urban centers.
Thousand Oaks is positioned between Los Angeles and Ventura County, giving companies access to a large workforce and a network of universities, research organizations, healthcare providers and other technology and life sciences businesses.
The area's existing biotechnology infrastructure is another advantage.
With Amgen and numerous other life sciences companies already established in Thousand Oaks, companies entering the market can become part of an existing industry cluster rather than operating in isolation.
Kite Pharma's decision to establish a home office presence in Thousand Oaks adds to that momentum.
A Growing Life Sciences Cluster in Ventura County
Ventura County has traditionally been known for agriculture, tourism, manufacturing and its coastal communities. However, the biotechnology and life sciences sector has become an increasingly important part of the county's business landscape.
Thousand Oaks sits at the center of much of that activity.
The continued presence of major biotechnology and pharmaceutical companies provides the Conejo Valley with an opportunity to expand its reputation as a destination for life sciences businesses.
Kite Pharma's move is one more piece of that larger development.
As biotechnology companies continue to research new cancer treatments, cell therapies and other medical technologies, communities with established life sciences infrastructure may have an opportunity to attract additional investment and talent.
What Kite Pharma's Relocation Could Mean for Thousand Oaks
The planned relocation could bring additional employees and business activity to Thousand Oaks while strengthening the city's connection to the Southern California biotechnology industry.
It also gives the Conejo Valley another nationally recognized biotechnology company alongside the area's existing life sciences businesses.
For local residents, the growth of the biotech industry could mean additional employment opportunities in fields ranging from science and medicine to information technology, engineering, operations and corporate services.
For local businesses, a growing concentration of biotech professionals and companies could create new demand for housing, restaurants, professional services, commercial real estate and other services throughout the Conejo Valley.
Kite Pharma Adds Momentum to Conejo Valley's Future
Kite Pharma's planned relocation of its home office to Thousand Oaks and El Segundo is another notable development for Southern California's biotechnology industry.
The company joins a growing group of life sciences businesses in the Conejo Valley, where Thousand Oaks has developed into one of Ventura County's most important centers for biotechnology and pharmaceutical activity.
With Amgen serving as a major anchor and companies such as Atara Biotherapeutics, Capsida Biotherapeutics, Latigo Biotherapeutics and Takeda contributing to the region's expanding life sciences presence, the Conejo Valley continues to attract attention from the biotechnology sector.
As Kite prepares to relocate its home office operations at the end of 2026, its arrival could further strengthen Thousand Oaks' position as a leading biotech and life sciences destination in Ventura County.
For residents of the 805 region, it is another sign that the Conejo Valley's role in Southern California's biotechnology economy continues to grow.
Published September 15, 2026, In 805 Media (in805.com)